- 1. APL unit
- [biologic activity of anticardiolipin IgA ( HL7V3.0 )] (UMLS (HL7) C1552996) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens | - 6. APLD
- [An anticancer drug obtained from a marine animal. ( NCI )] (UMLS (NCI) C0388638) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 2. Aplastic anemia and other bone marrow failure syndromes
- [ ] (UMLS (ICD9CM) C1719323) =Disease or Syndrome
| - 7. Aplysia
- [genus of motile gastropods with a poorly developed or missing shell; used in neurobiology studies because it possesses a simple nervous system with large, individually identifiable neurons. ( CSP )] (UMLS (CSP) C0003577) =Invertebrate ;
|
- 3. Aplastic Anemia due to Infection
- (UMLS (NCI) C0271912) =Disease or Syndrome
| - 8. Aplysia Ras-Related Homolog 12
- [RHO A GTP-binding protein is involved in regulating signal transduction pathways that control assembly of focal adhesions and actin stress fibers. Rho regulates remodeling of the actin cytoskeleton during cell morphogenesis and motility. Active Rho signals to its downstream effector ROCK1, which phosphorylates and activates LIM kinase. LIM kinase, in turn, phosphorylates cofilin, inhibiting its actin-depolymerizing activity. (from OMIM 165390 and NCI) ( NCI )] (UMLS (NCI) C0084340) =Amino Acid, Peptide, or Protein; Enzyme
|
- 4. Aplastic Anemia due to Radiation
- (UMLS (NCI) C0472734) =Disease or Syndrome
| - 9. Aplysia RAS-Related Homolog 9
- [RHO C protein is a product of the ARHC gene that regulates remodeling of the actin cytoskeleton during cell morphogenesis and motility. Rho C enhances metastasis when over expressed, whereas a dominant-negative Rho inhibits metastasis. Analysis of the phenotype of cells expressing dominant-negative Rho C indicates that Rho C is important in tumor cell invasion. (from OMIM 165380 and NCI) ( NCI )] (UMLS (NCI) C0084342) =Amino Acid, Peptide, or Protein; Enzyme
|
- 5. APLASTIC ANEMIAS NEC
- [ ] (UMLS (ICD9CM) C1955746) Other specified aplastic anemias;
=Disease or Syndrome | |
home
